Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 2Recruiting 1

Sponsor Class

INDUSTRY 8OTHER 3NIH 1NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Lymphoma, Non-Hodgkin 1Hodgkin Disease 1Fatigue 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2064Radiotherapy 1984Cisplatin 1851Carboplatin 1557Gemcitabine 1452Paclitaxel 1320Bevacizumab 1316pembrolizumab 1235Docetaxel 1225Oxaliplatin 1181Capecitabine 1173Fluorouracil 1081Dexamethasone 979Magnetic Resonance Spectroscopy 967Nivolumab 936Rituximab 928Drug Therapy 911Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 814Blood Specimen Collection 814Irinotecan 783Cytarabine 743fludarabine 723Leucovorin 682Surgical Procedures, Operative 638Lenalidomide 618Biopsy 592fludarabine phosphate 568

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Dextromethorphan × Clear all
NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting
10 enrolled
Lymphoid

Hodgkin Disease, Lymphoma, Non-Hodgkin

NCT00873366 2018-01-23

Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

Mayo Clinic

Terminated
92 enrolled 20 charts
Breast

Breast Neoplasms

NCT00176540 2011-05-17

Dextromethorphan in Treating Patients With Fatigue Caused by Cancer

Rutgers, The State University of New Jersey

Phase NA Terminated
30 enrolled

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡